Search

everythinglearnresearchcommunity

for

Search:↓

Allopregnanolone can reduce gut inflammation and normalize neurotransmitter levels after finasteride withdrawal.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

A breast cancer patient had lasting hair loss after chemotherapy, which improved with minoxidil treatment.

Platelet-rich plasma may help hair follicle cells grow by affecting certain genes and pathways.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Certain gene variations might be linked to severe acne in women but not in men.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Plant extracts in shampoo improved hair thickness and density in men with hair loss.

Certain drugs, especially antiandrogens and spironolactone, significantly increase the risk of gynecomastia.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with PCOS face many health risks, but exercise, a healthy diet, and weight management can help.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

No cure for female pattern hair loss, but various effective treatments exist.

Many males in Jordan misuse oral contraceptive pills for hair growth, muscle gain, and acne treatment.